Using mice treated with B7 antibodies and PD-L1 inhibitors, Kamphorst et al. demonstrated that CD28 inhibition resulted in progression of colon cancer, as did the suppression of T cell proliferation in CD28 knockout mice treated with PD-L1 inhibitors alone [39]. This evidence concerns the gene CD28 and malignant colon neoplasm.